Dapagliflozin reduces loop diuretic requirement over time in patients with heart failure with mildly reduced or preserved ejection fraction in the DELIVER Trial

被引：0

作者：

Chatur, Safia ^{[1
]}

Vaduganathan, M. ^{[1
]}

Claggett, B. ^{[1
]}

Vardeny, O. ^{[2
]}

Desai, A. S. ^{[1
]}

Jhund, P. S. ^{[3
]}

De Boer, R. A. ^{[4
]}

Lam, C. S. P. ^{[5
]}

Kosiborod, M. N. ^{[6
]}

Shah, S. J. ^{[7
]}

Martinez, F. ^{[8
]}

Inzucchi, S. E. ^{[9
]}

Hernandez, A. F. ^{[10
]}

Mc Murray, J. J. V. ^{[3
]}

Solomon, S. D. ^{[1
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA

[2] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA

[3] BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland

[4] Univ Med Ctr Groningen, Groningen, Netherlands

[5] Natl Heart Ctr Singapore, Singapore, Singapore

[6] St Lukes Mid Amer Heart Inst, Kansas City, MO USA

[7] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[8] Univ Nacl Cordoba, Cordoba, Argentina

[9] Yale Sch Med, New Haven, CT USA

[10] Duke Univ, Med Ctr, Duram, NC USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：39 / 40

页数：2